Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues

Go back to Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues

Applied DNA Sciences (APDN) Misses Q1 EPS by 36c

February 10, 2022 4:06 PM EST

Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.63), $0.36 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

... More